Form 4: Prothena Corp Director Lars Ekman Acquires 15,000 Stock Options
SEC Form 4
Director Lars Ekman reports acquisition of 15,000 stock options in Prothena Corp on May 15, 2024.
Summary
- On May 15, 2024, Lars Ekman, a director of Prothena Corp Public Ltd Co, acquired 15,000 stock options.
- The exercise price of these options is $22.39.
- The options vest on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025, assuming continuous service as a director.
- The options expire on May 15, 2034.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard transaction. The acquisition of stock options by a director is generally viewed as a positive signal, but it's not a major event.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the options is contingent upon continuous service as a director, suggesting an expectation of continued involvement by Lars Ekman.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: Lars Ekman acquired 15,000 stock options. |
| 05/15/2024 | Grant date of the stock options. |
| 05/15/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.